A49.8

Case	Control
333	459872

Location	SNP	Gene	Ref>Alt	Alt in Case	Alt in Control	Chi-square	P-value	Odds Ratio
chr20:5223865	rs78863898	-	G>A	22	10604	25.12	5.383e-07	2.826
chr17:46792918	rs77753764	-	C>T	71	53921	24.65	6.857e-07	1.843
chr4:188929600	rs6812408	-	A>G	147	134510	24.41	7.789e-07	1.572
chr5:78202968	rs11747224	ARSB	C>T	101	85123	24.18	8.778e-07	1.687
chr11:47519492	rs72907957	CELF1	G>C	32	18845	23.0	1.62e-06	2.322
chr18:77755460	rs57083541	TXNL4A	T>C	33	19735	22.92	1.687e-06	2.292
chr4:178787983	rs62342770	-	C>T	30	17353	22.58	2.011e-06	2.363
chr9:127676918	rs74759033	GOLGA1	G>A	50	35058	22.34	2.284e-06	1.974
chr5:130276362	rs2419757	-	A>T	28	16308	20.94	4.746e-06	2.355
chr1:5816959	rs80030164	-	G>A	21	10832	20.84	4.98e-06	2.647
chr10:3381474	rs10751920	-	T>C	68	53849	20.78	5.151e-06	1.774
chr2:127646281	rs7570970	-	C>T	138	129985	20.68	5.435e-06	1.533
chr11:55540964	rs117263837	OR5D13	G>T	20	10104	20.63	5.577e-06	2.691
chr5:169473172	rs10075025	DOCK2	A>G	31	18978	20.21	6.933e-06	2.234
chr6:31214171	rs73405036	-	G>A	30	18303	19.69	9.09e-06	2.239
chr16:28974658	rs8044999	NFATC2IP	A>G	37	24408	19.66	9.251e-06	2.08
chr1:20972111	rs3738136	PINK1	G>A	60	46681	19.6	9.55e-06	1.802
chr2:48633406	rs75792391	-	C>A	33	20932	19.53	9.895e-06	2.157
chr3:153522213	rs73174118	-	A>G	23	12698	19.49	1.01e-05	2.472
chr9:92118959	rs4877100	-	A>G	65	51305	19.4	1.063e-05	1.76
chr18:77755460	rs57083541	TXNL4A	T>C	29	15551	28.34	1.018e-07	2.646
chr23:151996723	rs142811420	CETN2	T>C	21	11427	24.2	8.673e-07	2.859
chr11:47519492	rs72907957	CELF1	G>C	31	18624	23.04	1.591e-06	2.356
chr3:153522213	rs73174118	-	A>G	23	12392	22.29	2.341e-06	2.625
chr2:48633406	rs75792391	-	C>A	33	20624	22.25	2.391e-06	2.27
chr4:33767083	rs73222427	-	G>A	22	11576	22.24	2.406e-06	2.673
chr2:235989360	rs77888970	-	G>A	22	11362	22.15	2.521e-06	2.671
chr8:35831522	rs118039006	-	T>C	22	12056	20.54	5.843e-06	2.58
chr10:3381474	rs10751920	-	T>C	58	45891	20.04	7.569e-06	1.834
chr6:502106	rs75891606	EXOC2	A>G	59	46638	19.88	8.229e-06	1.822
chr1:20972111	rs3738136	PINK1	G>A	53	41156	19.67	9.187e-06	1.869
chr4:188929600	rs6812408	-	A>G	125	119212	19.63	9.394e-06	1.547
chr9:127676918	rs74759033	GOLGA1	G>A	46	33875	19.52	9.966e-06	1.941
chr15:49480222	rs111395635	GALK2	A>C	33	21669	19.46	1.028e-05	2.158
chr11:55540964	rs117263837	OR5D13	G>T	19	9999	19.25	1.146e-05	2.67
chr12:92071674	rs118134441	-	T>C	22	12354	19.19	1.185e-05	2.504
chr3:52414112	rs73072968	DNAH1	C>T	32	20917	19.09	1.248e-05	2.166
chr11:48099242	rs72901575	PTPRJ	G>A	30	19242	19.0	1.308e-05	2.212
chr2:83936401	rs114861441	-	C>T	19	10055	18.99	1.315e-05	2.654
chr2:48076548	rs75315139	FBXO11	A>G	33	21958	18.86	1.406e-05	2.134
chr18:77755460	rs57083541	TXNL4A	T>C	29	15551	28.34	1.018e-07	2.646
chr23:151996723	rs142811420	CETN2	T>C	21	11427	24.2	8.673e-07	2.859
chr11:47519492	rs72907957	CELF1	G>C	31	18624	23.04	1.591e-06	2.356
chr3:153522213	rs73174118	-	A>G	23	12392	22.29	2.341e-06	2.625
chr2:48633406	rs75792391	-	C>A	33	20624	22.25	2.391e-06	2.27
chr4:33767083	rs73222427	-	G>A	22	11576	22.24	2.406e-06	2.673
chr2:235989360	rs77888970	-	G>A	22	11362	22.15	2.521e-06	2.671
chr8:35831522	rs118039006	-	T>C	22	12056	20.54	5.843e-06	2.58
chr10:3381474	rs10751920	-	T>C	58	45891	20.04	7.569e-06	1.834
chr6:502106	rs75891606	EXOC2	A>G	59	46638	19.88	8.229e-06	1.822
chr1:20972111	rs3738136	PINK1	G>A	53	41156	19.67	9.187e-06	1.869
chr4:188929600	rs6812408	-	A>G	125	119212	19.63	9.394e-06	1.547
chr9:127676918	rs74759033	GOLGA1	G>A	46	33875	19.52	9.966e-06	1.941
chr15:49480222	rs111395635	GALK2	A>C	33	21669	19.46	1.028e-05	2.158
chr11:55540964	rs117263837	OR5D13	G>T	19	9999	19.25	1.146e-05	2.67
chr12:92071674	rs118134441	-	T>C	22	12354	19.19	1.185e-05	2.504
chr3:52414112	rs73072968	DNAH1	C>T	32	20917	19.09	1.248e-05	2.166
chr11:48099242	rs72901575	PTPRJ	G>A	30	19242	19.0	1.308e-05	2.212
chr2:83936401	rs114861441	-	C>T	19	10055	18.99	1.315e-05	2.654
chr2:48076548	rs75315139	FBXO11	A>G	33	21958	18.86	1.406e-05	2.134

Location

SNP

Gene

Ref>Alt

Alt in Case

Alt in Control

Chi-square

P-value

Odds Ratio

chr20:5223865

rs78863898

-

G>A

22

10604

25.12

5.383e-07

2.826

chr17:46792918

rs77753764

-

C>T

71

53921

24.65

6.857e-07

1.843

chr4:188929600

rs6812408

-

A>G

147

134510

24.41

7.789e-07

1.572

chr5:78202968

rs11747224

ARSB

C>T

101

85123

24.18

8.778e-07

1.687

chr11:47519492

rs72907957

CELF1

G>C

32

18845

23.0

1.62e-06

2.322

chr18:77755460

rs57083541

TXNL4A

T>C

33

19735

22.92

1.687e-06

2.292

chr4:178787983

rs62342770

-

C>T

30

17353

22.58

2.011e-06

2.363

chr9:127676918

rs74759033

GOLGA1

G>A

50

35058

22.34

2.284e-06

1.974

chr5:130276362

rs2419757

-

A>T

28

16308

20.94

4.746e-06

2.355

chr1:5816959

rs80030164

-

G>A

21

10832

20.84

4.98e-06

2.647

chr10:3381474

rs10751920

-

T>C

68

53849

20.78

5.151e-06

1.774

chr2:127646281

rs7570970

-

C>T

138

129985

20.68

5.435e-06

1.533

chr11:55540964

rs117263837

OR5D13

G>T

20

10104

20.63

5.577e-06

2.691

chr5:169473172

rs10075025

DOCK2

A>G

31

18978

20.21

6.933e-06

2.234

chr6:31214171

rs73405036

-

G>A

30

18303

19.69

9.09e-06

2.239

chr16:28974658

rs8044999

NFATC2IP

A>G

37

24408

19.66

9.251e-06

2.08

chr1:20972111

rs3738136

PINK1

G>A

60

46681

19.6

9.55e-06

1.802

chr2:48633406

rs75792391

-

C>A

33

20932

19.53

9.895e-06

2.157

chr3:153522213

rs73174118

-

A>G

23

12698

19.49

1.01e-05

2.472

chr9:92118959

rs4877100

-

A>G

65

51305

19.4

1.063e-05

1.76

chr18:77755460

rs57083541

TXNL4A

T>C

29

15551

28.34

1.018e-07

2.646

chr23:151996723

rs142811420

CETN2

T>C

21

11427

24.2

8.673e-07

2.859

chr11:47519492

rs72907957

CELF1

G>C

31

18624

23.04

1.591e-06

2.356

chr3:153522213

rs73174118

-

A>G

23

12392

22.29

2.341e-06

2.625

chr2:48633406

rs75792391

-

C>A

33

20624

22.25

2.391e-06

2.27

chr4:33767083

rs73222427

-

G>A

22

11576

22.24

2.406e-06

2.673

chr2:235989360

rs77888970

-

G>A

22

11362

22.15

2.521e-06

2.671

chr8:35831522

rs118039006

-

T>C

22

12056

20.54

5.843e-06

2.58

chr10:3381474

rs10751920

-

T>C

58

45891

20.04

7.569e-06

1.834

chr6:502106

rs75891606

EXOC2

A>G

59

46638

19.88

8.229e-06

1.822

chr1:20972111

rs3738136

PINK1

G>A

53

41156

19.67

9.187e-06

1.869

chr4:188929600

rs6812408

-

A>G

125

119212

19.63

9.394e-06

1.547

chr9:127676918

rs74759033

GOLGA1

G>A

46

33875

19.52

9.966e-06

1.941

chr15:49480222

rs111395635

GALK2

A>C

33

21669

19.46

1.028e-05

2.158

chr11:55540964

rs117263837

OR5D13

G>T

19

9999

19.25

1.146e-05

2.67

chr12:92071674

rs118134441

-

T>C

22

12354

19.19

1.185e-05

2.504

chr3:52414112

rs73072968

DNAH1

C>T

32

20917

19.09

1.248e-05

2.166

chr11:48099242

rs72901575

PTPRJ

G>A

30

19242

19.0

1.308e-05

2.212

chr2:83936401

rs114861441

-

C>T

19

10055

18.99

1.315e-05

2.654

chr2:48076548

rs75315139

FBXO11

A>G

33

21958

18.86

1.406e-05

2.134

chr18:77755460

rs57083541

TXNL4A

T>C

29

15551

28.34

1.018e-07

2.646

chr23:151996723

rs142811420

CETN2

T>C

21

11427

24.2

8.673e-07

2.859

chr11:47519492

rs72907957

CELF1

G>C

31

18624

23.04

1.591e-06

2.356

chr3:153522213

rs73174118

-

A>G

23

12392

22.29

2.341e-06

2.625

chr2:48633406

rs75792391

-

C>A

33

20624

22.25

2.391e-06

2.27

chr4:33767083

rs73222427

-

G>A

22

11576

22.24

2.406e-06

2.673

chr2:235989360

rs77888970

-

G>A

22

11362

22.15

2.521e-06

2.671

chr8:35831522

rs118039006

-

T>C

22

12056

20.54

5.843e-06

2.58

chr10:3381474

rs10751920

-

T>C

58

45891

20.04

7.569e-06

1.834

chr6:502106

rs75891606

EXOC2

A>G

59

46638

19.88

8.229e-06

1.822

chr1:20972111

rs3738136

PINK1

G>A

53

41156

19.67

9.187e-06

1.869

chr4:188929600

rs6812408

-

A>G

125

119212

19.63

9.394e-06

1.547

chr9:127676918

rs74759033

GOLGA1

G>A

46

33875

19.52

9.966e-06

1.941

chr15:49480222

rs111395635

GALK2

A>C

33

21669

19.46

1.028e-05

2.158

chr11:55540964

rs117263837

OR5D13

G>T

19

9999

19.25

1.146e-05

2.67

chr12:92071674

rs118134441

-

T>C

22

12354

19.19

1.185e-05

2.504

chr3:52414112

rs73072968

DNAH1

C>T

32

20917

19.09

1.248e-05

2.166

chr11:48099242

rs72901575

PTPRJ

G>A

30

19242

19.0

1.308e-05

2.212

chr2:83936401

rs114861441

-

C>T

19

10055

18.99

1.315e-05

2.654

chr2:48076548

rs75315139

FBXO11

A>G

33

21958

18.86

1.406e-05

2.134

ID	Name	Top Correlation
HP: 0031549	Lymphocytoma cutis	1/20
HP: 0500028	Cotton wool plaques	1/20

ID	Name	Top Correlation
HP: 0000118	Phenotypic abnormality	0/20
HP: 0000152	Abnormality of head or neck	0/20
HP: 0000234	Abnormality of the head	0/20
HP: 0000245	Abnormality of the paranasal sinuses	0/20
HP: 0000246	Sinusitis	0/20
HP: 0000255	Acute sinusitis	0/20
HP: 0000271	Abnormality of the face	0/20
HP: 0000315	Abnormality of the orbital region	0/20
HP: 0000502	Abnormal conjunctiva morphology	0/20
HP: 0000707	Abnormality of the nervous system	0/20
HP: 0000924	Abnormality of the skeletal system	0/20
HP: 0000929	Abnormal skull morphology	0/20
HP: 0000951	Abnormality of the skin	0/20
HP: 0001055	Erysipelas	0/20
HP: 0001574	Abnormality of the integument	0/20
HP: 0002011	Morphological central nervous system abnormality	0/20
HP: 0002086	Abnormality of the respiratory system	0/20
HP: 0002664	Neoplasm	0/20
HP: 0002715	Abnormality of the immune system	0/20
HP: 0002718	Recurrent bacterial infections	0/20
HP: 0002719	Recurrent infections	0/20
HP: 0002740	Recurrent E. coli infections	0/20
HP: 0002795	Functional respiratory abnormality	0/20
HP: 0005420	Recurrent gram-negative bacterial infections	0/20
HP: 0007367	Atrophy/Degeneration affecting the central nervous system	0/20
HP: 0008069	Neoplasm of the skin	0/20
HP: 0009121	Abnormal axial skeleton morphology	0/20
HP: 0010978	Abnormality of immune system physiology	0/20
HP: 0011121	Abnormality of skin morphology	0/20
HP: 0011122	Abnormality of skin physiology	0/20
HP: 0011123	Inflammatory abnormality of the skin	0/20
HP: 0011355	Localized skin lesion	0/20
HP: 0011793	Neoplasm by anatomical site	0/20
HP: 0011821	Abnormality of facial skeleton	0/20
HP: 0011842	Abnormality of skeletal morphology	0/20
HP: 0012322	Perifolliculitis	0/20
HP: 0012639	Abnormal nervous system morphology	0/20
HP: 0012647	Abnormal inflammatory response	0/20
HP: 0012649	Increased inflammatory response	0/20
HP: 0030350	Erythematous papule	0/20
HP: 0030669	Abnormal ocular adnexa morphology	0/20
HP: 0030829	Abnormal breath sound	0/20
HP: 0030831	Rhonchi	0/20
HP: 0030947	Conjunctival follicles	0/20
HP: 0032039	Abnormality of the ocular adnexa	0/20
HP: 0032101	Unusual infection	0/20
HP: 0100256	Senile plaques	0/20
HP: 0200034	Papule	0/20

Other bacterial infections of unspecified site

A49.8

Case/Control GWAS ^ⓘ

Links

Statistics

Top SNP Information

Associated Phenotypes ^ⓘ

Other bacterial infections of unspecified site

A49.8

Case/Control GWAS ⓘ

Links

Statistics

Top SNP Information Show Table

Associated Phenotypes ⓘ Shared SNP phenotypes No shared SNP phenotypes

Case/Control GWAS ^ⓘ

Top SNP Information

Associated Phenotypes ^ⓘ